1. National Heart and Lung Institute, Imperial College London, London, United Kingdom
2. Royal Brompton Hospital, London, United Kingdom; and
3. Fibrosis Discovery Performance Unit, GlaxoSmithKline R&D, GlaxoSmithKline Medicines Research Centre, Stevenage, United Kingdom